Oncology

Proxime Accessit to the University of London Gold Medal

2020

Draper's Prize for academic achievement

2020

Early phase clinical trials incorporating biomarker analyses/development. 

Developing biomarkers for diagnostics and therapeutics for GI cancers

Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.

THE LANCET Oncology – Catenacci DVT, Kang YK, Park H, Uronis HE, Lee KW, Ng MCH, Enzinger PC, Park SH, Gold PJ, Lacy J, Hochster HS, Oh SC, Kim YH, Marrone KA, Kelly RJ, Juergens RA, Kim JG, Bendell JC, Alcindor T, Sym SJ, Song EK, Chee CE, Chao Y, Kim S, Lockhart AC, Knutson KL, Yen J, Franovic A, Nordstrom JL, Li D, Wigginton J, Davidson-Moncada JK, Rosales MK, Bang YJ (2020)

21 (8); 1066-1076

A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer.

European journal of cancer (Oxford, England : 1990) – Bang Y-J; Kang Y-K; Ng M; Chung H C; Wainberg Z A; Gendreau S; Chan W Y; Xu N; Maslyar D; Meng R; Chau I; Ajani J A (2019)

108 17-24

PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.

Nature communications – Thura Min; Al-Aidaroos Abdul Qader; Gupta Abhishek; Chee Cheng Ean; Lee Soo Chin; Hui Kam Man; Li Jie; Guan Yeoh Khay; Yong Wei Peng; So Jimmy; Chng Wee Joo; Ng Chin Hin; Zhou Jianbiao; Wang Ling Zhi; Yuen John Shyi Peng; Ho Henry Sun Sien; Yi Sim Mei; Chiong Edmund; Choo Su Pin; Ngeow Joanne; Ng Matthew Chau Hsien; Chua Clarinda; Yeo Eugene Shen Ann; Tan Iain Bee Huat; Sng Joel Xuan En; Tan Nicholas Yan Zhi; Thiery Jean Paul; Goh Boon Cher; Zeng Qi (2019)

10 (1);

Combined PIK3CA and FGFR Inhibition With Alpelisib and Infigratinib in Patients With PIK3CA-Mutant Solid Tumors, With or Without FGFR Alterations

JCO Precision Oncology – Hyman DM, Tran B, Paz-Ares L, Machiels JP, Schellens JH, Bedard PL, Campone M, Cassier PA, Sarantopoulos J, Vaishampayan U, Chugh R, Mahipal A, Lockhart AC, Sessa C, Zander T, Ng M, Curigliano G, Bendiske J, Chen X, Choudhury S, Grau-Porta D, Lewis N, Garcia JMP, Miguel-Luken MJ et al: (2019)

3

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Annals of oncology : official journal of the European Society for Medical Oncology – Muro K; Lordick F; Tsushima T; Pentheroudakis G; Baba E; Lu Z; Cho B C; Nor I M; Ng M; Chen L-T; Kato K; Li J; Ryu M-H; Zamaniah W I Wan; Yong W-P; Yeh K-H; Nakajima T E; Shitara K; Kawakami H; Narita Y; Yoshino T; Van Cutsem E; Martinelli E; Smyth E C; Arnold D; Minami H; Tabernero J; Douillard J-Y (2019)

30 (1); 34-43

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.

Annals of oncology : official journal of the European Society for Medical Oncology – Muro K; Van Cutsem E; Narita Y; Pentheroudakis G; Baba E; Li J; Ryu M-H; Zamaniah W I Wan; Yong W-P; Yeh K-H; Kato K; Lu Z; Cho B C; Nor I M; Ng M; Chen L-T; Nakajima T E; Shitara K; Kawakami H; Tsushima T; Yoshino T; Lordick F; Martinelli E; Smyth E C; Arnold D; Minami H; Tabernero J; Douillard J-Y (2019)

30 (1); 19-33

HER2 positive rates are enriched amongst colorectal cancer brain metastases: a study amongst 1920 consecutive patients.

Annals of oncology : official journal of the European Society for Medical Oncology – Tan R Y C; Camat M D; Ng M; Lim T H; Lim A S T; Lim K H; Tan I B H (2018)

29 (7); 1598-1599

Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research – Yong Wei Peng; Rha Sun Young; Tan Iain Bee-Huat; Choo Su-Pin; Syn Nicholas L; Koh Vivien; Tan Shi-Hui; Asuncion Bernadette Reyna; Sundar Raghav; So Jimmy Bok-Yan; Shabbir Asim; Tan Chee-Seng; Kim Hyo-Song; Jung Minkyu; Chung Hyun Cheol; Ng Matthew C H; Tai David Wai-Meng; Lee Ming-Hui; Wu Jeanie; Yeoh Khay Guan; Tan Patrick; (2018)

24 (21); 5272-5281

Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.

British journal of cancer – Ng M; Waters J; Cunningham D; Chau I; Horwich A; Hill M; Norman A R; Wotherspoon A; Catovsky D (2005)

92 (8); 1352-7

The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC).

European journal of cancer (Oxford, England : 1990) – Ng Matthew; Cunningham David; Norman Andrew R (2005)

41 (11); 1542-6